FILTER

FILTERED INTERVIEW RESULTS

Asimwe Kabunga

CHAIRMAN, LINDIAN RESOURCES
Lindian Resources is extending its portfolio of assets in Africa from bauxite in Guinea to rare earths in Malawi.

Asimwe Kabunga

CHAIRMAN, LINDIAN RESOURCES LIMITED
"With near-term export options, exceptional quality material and a multi-generational resource base, Lindian is well placed to become the best bauxite development company in the world."

Dolores Biamou

MINING PROJECTS DIRECTOR AFRICA, BOLLORÉ LOGISTICS
Bolloré Logistics explains how it has been able to maintain the supply chain for mines in Africa despite the pandemic and security threats.

John Kwofie & Ivan Doku

PRINCIPAL MINING ENGINEER AND COUNTRY MANAGER & PRINCIPAL RESOURCE GEOLOGIST AND COUNTRY MANAGER-DESIGNATE, SRK CONSULTING
An overview of the firm’s activities in West Africa.

Todd Burns

PRESIDENT, CYPHER ENVIRONMENTAL
Cypher Environmental provides solutions for stabilizing roads and suppressing dust in an environmentally friendly manner.

Paul Roberts

MANAGING DIRECTOR, PREDICTIVE DISCOVERY
Predictive Discovery explains progress at its Bankan discovery in Guinea, which holds a special place in the company’s West African portfolio.

Martin van Gemert

MANAGING DIRECTOR, MINCON WEST AFRICA
Mincon comments on its business with the mining sector in West Africa.

Danny Callow

CEO, AFRICAN GOLD GROUP (AGG)
African Gold Group explains its ambitions in West Africa where it’s Kobada gold mine is under construction.

Martin van Gemert

MANAGING DIRECTOR, MINCON WEST AFRICA
Mincon West Africa is an engineering company that specializes in hard-rock drilling tools.

Joel Cavaille & Samuel Modicom

CEO, JA DELMAS & COUNTRY MANAGER, SAUDEQUIP
Saudequip supplies the Caterpillar brand across francophone West Africa and is benefitting from the region’s current boom in mining.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.

PARTNER EVENTS